Harrow Inc (HROW)
17.50
+0.28
(+1.63%)
USD |
NASDAQ |
May 23, 16:00
17.47
-0.03
(-0.17%)
After-Hours: 20:00
Harrow Enterprise Value: 727.01M for May 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 23, 2024 | 727.01M |
| May 22, 2024 | 717.10M |
| May 21, 2024 | 691.27M |
| May 20, 2024 | 701.88M |
| May 17, 2024 | 700.82M |
| May 16, 2024 | 679.59M |
| May 15, 2024 | 671.28M |
| May 14, 2024 | 682.42M |
| May 13, 2024 | 534.88M |
| May 10, 2024 | 518.25M |
| May 09, 2024 | 471.90M |
| May 08, 2024 | 472.96M |
| May 07, 2024 | 494.90M |
| May 06, 2024 | 478.98M |
| May 03, 2024 | 475.08M |
| May 02, 2024 | 484.28M |
| May 01, 2024 | 476.85M |
| April 30, 2024 | 468.36M |
| April 29, 2024 | 483.57M |
| April 26, 2024 | 480.39M |
| April 25, 2024 | 461.64M |
| April 24, 2024 | 471.19M |
| April 23, 2024 | 472.96M |
| April 22, 2024 | 482.87M |
| April 19, 2024 | 477.56M |
| Date | Value |
|---|---|
| April 18, 2024 | 491.71M |
| April 17, 2024 | 526.03M |
| April 16, 2024 | 543.02M |
| April 15, 2024 | 544.78M |
| April 12, 2024 | 555.39M |
| April 11, 2024 | 574.50M |
| April 10, 2024 | 565.30M |
| April 09, 2024 | 575.20M |
| April 08, 2024 | 575.20M |
| April 05, 2024 | 585.82M |
| April 04, 2024 | 573.08M |
| April 03, 2024 | 571.31M |
| April 02, 2024 | 545.84M |
| April 01, 2024 | 560.70M |
| March 31, 2024 | 575.91M |
| March 28, 2024 | 567.90M |
| March 27, 2024 | 550.22M |
| March 26, 2024 | 544.91M |
| March 25, 2024 | 524.40M |
| March 22, 2024 | 506.72M |
| March 21, 2024 | 474.19M |
| March 20, 2024 | 472.07M |
| March 19, 2024 | 476.66M |
| March 18, 2024 | 471.00M |
| March 15, 2024 | 468.97M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
73.09M
Minimum
Mar 23 2020
987.44M
Maximum
May 09 2023
308.61M
Average
223.86M
Median
Enterprise Value Benchmarks
| Durect Corp | 32.28M |
| Aquestive Therapeutics Inc | 213.07M |
| Cyclacel Pharmaceuticals Inc | 0.2018M |
| Stereotaxis Inc | 154.77M |
| Cara Therapeutics Inc | -29.65M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -13.56M |
| Revenue (Quarterly) | 34.59M |
| Total Expenses (Quarterly) | 41.52M |
| EPS Diluted (Quarterly) | -0.38 |
| Gross Profit Margin (Quarterly) | 69.49% |
| Profit Margin (Quarterly) | -39.22% |
| Earnings Yield | -5.26% |
| Normalized Earnings Yield | -5.106 |